French health minister estimates annual cost at around €100 million
French citizens will now be able to gain limited reimbursement for blockbuster weight-loss drugs such as Wegovy and Mounjaro, which European insurers have been wary of covering due to high costs.
Speaking to French broadcaster TF1, French Health Minister Stéphanie Rist said it was the first European country to decide to cover the costly, yet popular drugs for obesity patients.
“We are the first country in the European Union to provide reimbursement for patients who need it, under general law, on a permanent basis,” Rist said.
Log in to continue reading for free
